Your browser doesn't support javascript.
loading
Identifying kinase targets of PPARγ in human breast cancer.
Kandel, Anish; Dhillon, Sarinder Kaur; Prabaharan, Chandra Bose; Fatnin Binti Hisham, Syaza; Rajamanickam, Karthic; Napper, Scott; Chidambaram, Saravana Babu; Essa, Musthafa Mohamed; Yang, Jian; Sakharkar, Meena Kishore.
Afiliação
  • Kandel A; Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
  • Dhillon SK; Faculty of Science, Institute of Biological Sciences, University of Malaya, Kuala Lumpur, Malaysia.
  • Prabaharan CB; Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
  • Fatnin Binti Hisham S; Faculty of Science, Institute of Biological Sciences, University of Malaya, Kuala Lumpur, Malaysia.
  • Rajamanickam K; Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
  • Napper S; Vaccine and Infectious Disease Organization-International Vaccine Research Centre, University of Saskatchewan, Saskatoon, Canada.
  • Chidambaram SB; Department of Biochemistry, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
  • Essa MM; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research (JSSAHER), Mysuru, India.
  • Yang J; Ageing and Dementia Research Group, Sultan Qaboos University, Muscat, Oman.
  • Sakharkar MK; Department of Food Science and Nutrition, College of Agricultural and Marine Sciences, Sultan Qaboos University, Muscat, Oman.
J Drug Target ; 29(6): 660-668, 2021 07.
Article em En | MEDLINE | ID: mdl-33496213
ABSTRACT
Breast cancer is the most common cancer in women. Despite advances in screening women for genetic predisposition to breast cancer and risk stratification, a majority of women carriers remain undetected until they become affected. Thus, there is a need to develop a cost-effective, rapid, sensitive and non-invasive early-stage diagnostic method. Kinases are involved in all fundamental cellular processes and mutations in kinases have been reported as drivers of cancer. PPARγ is a ligand-activated transcription factor that plays important roles in cell proliferation and metabolism. However, the complete set of kinases modulated by PPARγ is still unknown. In this study, we identified human kinases that are potential PPARγ targets and evaluated their differential expression and gene pair correlations in human breast cancer patient dataset TCGA-BRCA. We further confirmed the findings in human breast cancer cell lines MCF7 and SK-BR-3 using a kinome array. We observed that gene pair correlations are lost in tumours as compared to healthy controls and could be used as a supplement strategy for diagnosis and prognosis of breast cancer.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfotransferases / Neoplasias da Mama / PPAR gama Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfotransferases / Neoplasias da Mama / PPAR gama Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article